Metrics Champion Consortium - Overview
Today's drug development industry is under increased pressure to improve its research and development performance/strategies by reducing drug development times and costs, while at the same time dramatically increasing productivity and maintaining quality. Biotechnology and pharmaceutical organizations that are currently achieving efficient clinical trial cycle times attribute their success to the following "best practices":
- Maintaining focus on core competencies
- Prioritizing the utilization of resources
- Outsourcing services
The utilization of standardized performance metrics by the drug development industry to reduce clinical development times and to improve clinical trial deliverables is essential to its success. Sponsors and service providers need to effectively manage and track their resources, including people, time, and money, as each has an impact on productivity and efficiency over the course of a clinical trial.
ERT's Performance At A Glance
- Percentage of on-time ECG Equipment shipments to sites: 100%
- Percentage of on-time, accepted ECG file transfers: 100%
- Percentage of ECG core lab audit/assessment findings closed within agreed timelines: 100%
- Percentage of ECGs reported to Investigator Sites within agreed turnaround time: 99.6%
